NextCure

Biotechnology Research • Beltsville, Maryland, United States • 51-100 Employees

Company overview

Headquarters	9000 Virginia Manor Rd, 200, Beltsville, Maryland 20705, US
Phone number	+12403994900
Website	nextcure.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Drug Development, Cancer Therapy
Employees	51-100
Socials

Key Contacts at NextCure

Hariff Davies

Director, Project Management And Planning

Jingning Li

Associate Director

Shanmugam Panneer Selvam

Director Of Business Development

Curtis D. Gallagher

Associate Director, Downstream Development & Reagent Production

Tasneem Bahrainwala

Senior Director | Head Analytical Development And Quality Control

Thomas Schaffer

Director, Neuroimmune Research

Jason Bosiacki

Director, Manufacturing Operations - Projects

Ashley Muzza

Director Of Clinical Operations

Nate Brech

Associate Director, Development And Manufacturing

Stephanie Kordahi

Senior Director Clinical Operations

NextCure Email Formats

NextCure uses 2 email formats. The most common is {last name}{first initial} (e.g., doej@nextcure.com), used 94.3% of the time.

Format	Example	Percentage
{last name}{first initial}	doej@nextcure.com	94.3%
{last name}{last name}	doedoe@nextcure.com	5.7%

About NextCure

NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

NextCure revenue & valuation

Annual revenue	$48,400,000
Revenue per employee	$948,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$154,800,000
Total funding	$152,000,000